Efficacy of second CAR-T (CART2) infusion limited by poor CART expansion and antigen modulationElizabeth M. Holland, Nirali N. Shah, Daniel W Lee et al.|Journal for ImmunoTherapy of Cancer|2022Cited by 59
Multicentric Castleman disease and the evolution of the conceptTing Zhou, Elaine S. Jaffe, Hao‐Wei Wang et al.|Pathologica|2021Cited by 27
Antigen Loss after Targeted Immunotherapy in Hematological MalignanciesTing Zhou, Hao‐Wei Wang|Clinics in Laboratory Medicine|2021Cited by 22
A novel approach for characterization of <scp>KSHV</scp>‐associated multicentric Castleman disease from effusionsTing Zhou, Hao‐Wei Wang, Constance M. Yuan et al.|British Journal of Haematology|2022Cited by 19
Daratumumab induces cell-mediated cytotoxicity of primary effusion lymphoma and is active against refractory diseasePrabha Shrestha, Robert Yarchoan, Yana Astter et al.|OncoImmunology|2023Cited by 12